Vevizye is used to treat moderate to severe DED in adults unresponsive to tear substitutes. Novaliq and Laboratoires Théa ...

Resolution plans to use Series B investment to advance the development of its macrophage therapies in inflammatory and ...

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

Enara Bio has raised $32.5m in a Series B financing round to advance its platform shining a light on cancer-specific antigens ...

Novo Nordisk’s chief scientific officer Marcus Schindler led the keynote address at ELRIG Drug Discovery 2024 in London, UK.

Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing ...

ImmunoPrecise Antibodies, an AI-driven biotherapeutic research and technology company, has entered into a material transfer ...

Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...

Sofgen, a supplier of softgel technologies for generics, prescription drugs, OTC products and specialised nutraceuticals, ...

Under the terms of the deal announced yesterday (30 September), Massachusetts-based Prime Medicine will design gene editing ...

Exscientia detailed how its robotics lab in Oxfordshire, UK is increasing productivity and efficiency in developing new ...